INHIBITEX FILES $125 MLN MIXED SHELF

Biopharmaceutical company Inhibitex Inc. (INHX.O: Quote, Profile, Research) may periodically sell up to $125 million in common stock and warrants, according to a regulatory filing on Wednesday. The Alpharetta, Georgia-based company said it plans to use the proceeds for general corporate purposes including development of its product candidates, according to the filing with the U.S. Securities and Exchange Commission.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=bondsNews&storyID=2005-10-19T205928Z_01_WBT004043_RTRIDST_0_HEALTH-INHIBITEX-SHELF-URGENT.XML)